https://thebearcave.substack.com/p/problems-at-freedom-holding-corp?s=r
Navidea Stock Gains After FDA Grants End Of Phase 2 Meeting To Discuss Rheumatoid Arthritis Program
The FDA has granted Navidea Biopharmaceuticals Inc’s (NYSE:NAVB) request for an End-of-Phase 2 Type B meeting to discuss its ongoing program in…